Skip to main content

Iovance Biotherapeutics, Inc.

IOVA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001425205

No open-market purchases or sales by Iovance Biotherapeutics, Inc. insiders were filed in the last 90 days; 293 institutions reported holding it in 13F filings for Q2 2026, worth $1.19B in total; no superinvestor holds it.

Q4 2025 vs. Q3 2025

How the institutions holding Iovance Biotherapeutics, Inc. changed between Q3 2025 and Q4 2025.

All holders in Q4 2025All holders in Q3 2025

13F holders of IOVA: Q3 2025 compared with Q4 2025
MeasureQ3 2025Of which not filed for Q4 2025Q4 2025Change
Holders2535263+15
Shares213.0M74.5K261.6M+48.6M (+22.8%)
Value$462.3M$163.2K$713.7M+$251.6M (+54.4%)

5 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (51)

Institutions that held Iovance Biotherapeutics, Inc. at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to IOVA in Q4 2025
InstitutionSharesValue% of portfolio
Renaissance Technologies LLC651,000$1.78M0.00%
Qube Research & Technologies Ltd564,519$1.54M0.00%
Algert Global LLC433,999$1.18M0.02%
Quadrature Capital Ltd318,703$870.1K0.01%
Jain Global LLC312,096$852.0K0.01%
Corsair Capital Management, L.P.300,000$819.0K0.14%
Scientech Research LLC211,477$577.3K0.36%
Engineers Gate Manager LP194,691$531.5K0.01%
EFG International AG168,000$458.6K0.01%
Perceptive Advisors LLC152,714$416.9K0.01%
Quantitative Investment Management, LLC138,583$378.0K0.04%
MML Investors Services, LLC111,848$305.3K0.00%
Sugar Maple Asset Management, LLC110,000$300.3K0.20%
VARCOV Co.92,806$253.4K0.10%
Headlands Technologies LLC70,662$192.9K0.02%
Penbrook Management LLC33,945$92.7K0.06%
DRW Securities, LLC28,558$78.0K0.01%
Jump Financial, LLC22,062$60.2K0.00%
CIBC World Markets Corp20,344$55.5K0.00%
One68 Global Capital, LLC20,000$55.0K0.65%
Destination Wealth Management20,000$54.6K0.00%
Shay Capital LLC20,000$54.6K0.01%
Dynamic Technology Lab Private Ltd16,872$46.0K0.01%
Pathstone Holdings, LLC16,273$44.4K0.00%
Bayesian Capital Management, LP15,300$41.8K0.10%
Excelsior Advisor Network LLC15,150$41.4K0.02%
Two Sigma Securities, LLC14,040$38.3K0.01%
Jacobs Levy Equity Management, Inc12,788$34.9K0.00%
JustInvest LLC12,637$34.5K0.00%
Walleye Trading LLC11,952$32.6K0.00%
M&T Bank Corp11,464$31.3K0.00%
Motley Fool Asset Management LLC10,760$29.4K0.00%
Granite Investment Partners, LLC10,638$29.0K0.00%
Arcataur Capital Management LLC10,600$28.9K0.01%
Wealth Enhancement Trust Services, Inc.4,000$10.9K0.00%
Clear Street Markets LLC2,819$7.70K0.00%
GAMMA Investing LLC2,813$7.68K0.00%
Keating Financial Advisory Services, Inc.2,500$6.83K0.00%
Smartleaf Asset Management LLC2,090$5.79K0.00%
Valley National Advisers Inc1,680$4.00K0.00%
Torren Management, LLC1,348$3.68K0.00%
Bell Investment Advisors, Inc1,070$2.92K0.00%
Navalign, LLC1,000$2.73K0.00%
TD Private Client Wealth LLC314$8570.00%
Parkside Financial Bank & Trust300$8190.00%
Optima Capital LLC242$6610.00%
Basecamp Wealth Advisors LLC150$4100.00%
Basepoint Wealth LLC49$1330.00%
Aster Capital Management (DIFC) Ltd25$680.00%
CWM Advisors, LLC11$300.00%
Dunhill Financial, LLC3$90.00%

Sold out (36)

Institutions that held Iovance Biotherapeutics, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.

Not filed for Q4 2025 yet (5)

Institutions that held Iovance Biotherapeutics, Inc. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding IOVA in Q3 2025 that haven't filed for Q4 2025
InstitutionShares, Q3 2025Value, Q3 2025
CIBC Bancorp USA Inc.27,834$60.4K
Wolverine Trading, LLC21,739$48.5K
Sheets Smith Investment Management20,390$44.2K
Shell Asset Management Co4,454$10.0K
Binnacle Investments Inc38$82